A congressional committee has scheduled a hearing for next week focused on the Food and Drug Administration (FDA), inviting a hemp industry representative to testify on how the agency “failed” to approve certain products such as CBD.
The House Oversight Committee hearing—titled “Restoring Trust in FDA: Rooting Out Illicit Products”—is set to take place on Wednesday.
FDA “failed to approve products and take necessary enforcement actions resulting in a flood of illicit and counterfeit products entering the country,” a memo on the hearing says.